Every year in the United States, millions of MRI (magnetic resonance imaging) scans are performed to diagnose a wide variety of injuries and diseases. The images provided have helped save countless people whose afflictions would otherwise not have been identifiable.
However, more patients are claiming gadolinium-based contrast agents are putting patients at risk of potentially deadly side effects. The substance injected before MRIs may affect the kidneys and result in a condition known as nephrogenic systemic fibrosis (NSF). Some have reported side effects to other organs as well.
As a result of the rise in complications, hundreds of patients have filed lawsuits against the makers of gadolinium-based contrast agents over allegations that they failed to warn the public about their risks.
Patients adversely affected by gadolinium are actively seeking personal injury lawyers to get compensation for medical bills, lost wages, and their pain and suffering. Law firms looking for gadolinium cases can find pre-qualified and fully examined signed cases with Broughton Partners. Our legal case generation services connect retained plaintiffs with personal injury law firms such as yours. Your law firm can get gadolinium lawsuit leads delivered with relevant case documents by contacting our team at (912)-304-4444 or fill out a quick online form.
How Does Broughton Partners Acquire Gadolinium Lawsuit Leads?
Our experienced in-house marketing team begins by targeting and connecting with victims that are searching for information about gadolinium and if they have a lawsuit. We then begin tracking gadolinium lawsuit leads online with our industry-leading case-acquisition platform as soon as potential gadolinium plaintiffs show interest or after they call.
We have our very own in-house call center, open and working 24 hours with multi-lingual specialists. Each of our intake associates are highly trained individuals who know how to handle intake sessions with quality and compassion. The gadolinium cases we come into contact with will be reviewed will by our in-house call center via customized questions and a qualification process that is based on your law firm’s gadolinium case criteria.
When our team finds a qualified gadolinium lawsuit lead, we then gather appropriate case documents that your law firm would need to start working the case right away.
We Provided More Than Just Gadolinium Case Leads
Broughton Partners doesn’t just deliver retained gadolinium plaintiffs, we go further by providing gadolinium lawsuit leads with pre-packaged case documents such as hospital files and product information. We want to save your law firm’s time and give you everything you need to start working the case immediately. The gadolinium lawsuit leads that are provided by Broughton Partners are real victims who have legitimate gadolinium cases.
It can be difficult to find gadolinium lawsuit leads, especially leads that are high-quality with retained claimants. Save time and let us do the tedious work for you by reviewing potential gadolinium lawsuit leads and delivering only the best cases to your law firm.
What Are Gadolinium-Based Contrast Agents (GBCAs)?
A gadolinium contrast medium, also known as an MRI contrast agent or dye, is a chemical substance injected into the body before an MRI to enhance the images. The enhancement allows the radiologist to better analyze the images to report the findings to a doctor.
GBCAs are composed of molecules held together by chemical bonds, according to Inside Radiology. The gadolinium is bonded to a chelating agent to counter the toxicity of the chemical element while maintaining its magnetic properties.
There are several types of dyes containing gadolinium. These are the trade names GBCAs approved for use by the U.S. Food and Drug Administration, according to Medscape:
The dye is typically injected intravenously near the site of the scan and is later naturally removed from the body through the kidneys.
Gadolinium MRI Toxicity
Millions of people around the world have used MRI (Magnetic Resonance Imaging) scans to look for or diagnose diseases and injuries. But mounting evidence suggests that the contrast agents containing gadolinium used to enhance the images may put patients at risk for developing potentially lethal side effects.
Although the only known health effects related to gadolinium exposure is a condition that affects the kidneys called nephrogenic systemic fibrosis (NSF), patients also claim the contrast agents have led to problems with other organ systems as well.
Patients are now fighting back against the makers of gadolinium-based contrast agents through lawsuits.
What is an MRI?
An MRI is an imaging technique used in radiology to create accurate pictures of the body. Unlike CT scans, MRI scanners do not use X-rays. Instead, they use magnetic fields and radio waves to examine internal body structures.
A person is placed inside a large machine and must remain still while the imaging is processed. A typical MRI scan lasts anywhere between 30 to 60 minutes. However, some scans may take longer.
MRI scans are most commonly used to take images of the knees and shoulders to detect injuries. They can also be used on the head and neck to detect brain tumors, stroke, dementia, multiple sclerosis, aneurysms, spinal tumors, and more.
How Does Gadolinium Work with MRIs?
Gadolinium is a chemical element — a heavy metal found on the periodic table with the symbol Gd — that is combined with other chemicals to enhance the image quality of MRI scans.
According to Inside Radiology, a Gadolinium contrast medium is used in roughly 1 out of every 3 MRI scans. It is injected near the site of the scan and may be recommended by the doctor or radiologist.
Several different manufacturers make gadolinium contrast media, but they generally work by shortening spin-lattice relaxation time (T1) to increase the contrast of MRI imaging.
According to the American College of Radiology, more than 300 million patients around the world have used gadolinium-based contrast agents for diagnosis and treatment since it was first approved by the U.S. Food and Drug Administration in 1988.
When is Gadolinium Dye Necessary?
One out of every three MRI scans requires gadolinium dyes, according to Inside Radiology. Gadolinium agents have been used in roughly 300 million patients around the world. In some cases, certain cancers or diseases may be undetectable if an MRI is performed without a dye.
A doctor will typically inform the radiologist whether a contrast dye is needed before an MRI. Occasionally, the radiologist might determine that a gadolinium injection would greatly improve the quality of the images.
Before gadolinium dye is administered, a patient will be asked several questions to find out if they can receive an injection. For example, if a patient is pregnant or suffers from severe kidney disease, it may be recommended that the scan is done without the dye.
However, depending on the nature of the problem, a second scan may be performed using a GBCA.
Gadolinium Side Effects
Side effects can occur for those injected with gadolinium-based contrast agents. However, they are often mild. The most common side effects are headaches, nausea, itchiness, dizziness, vomiting, and inflammation.
In some cases, patients may have allergic reactions to gadolinium, which ranges from mild to severe. Reactions may manifest itself as itchy eyes, hives, skin irritation, breathing issues, and chest tightness.
Gadolinium Linked to Nephrogenic Systemic Fibrosis
One of the most severe side effects connected to gadolinium is a condition called nephrogenic systemic fibrosis (NSF). NSF is a rare disease that develops in some people with reduced kidney function after exposure to gadolinium-based contrast agents.
According to the National Organization for Rare Disorders, the disease may develop slowly over a period of time. The severity and progression of the disease varies by person but can come on rapidly and lead to potentially life-threatening complications.
Symptoms of NSF include (but are not limited to):
- Swelling or tightening of the skin
- Darkened patches, especially on extremities
- Skin hardening
- Loss of flexibility
- Chronic pain in the skin
- Muscle weakness
- Bent joints
- Blood clots
So far, the disease has not yet been reported in individuals with normal kidney function. NSF may also affect multiple organ systems, depending on the person, and may include complications involving the kidney or heart.
History of Gadolinium
Nephrogenic systemic fibrosis was first identified in 1997, but researchers now believe that the rise in NSF since then is directly related to the increased use of gadolinium-based contrast agents.
It wasn’t until 2006 when European investigators identified a possible association between NSF and gadolinium dyes that the public became aware of the dangers of gadolinium. That same year, the U.S. Food and Drug Administration issued a public health advisory on potential risks.
In a review of post-marketing reports, the FDA found reports of patients who developed the rare disease after being exposed to five gadolinium-based contrast agents currently approved in the U.S. for MRI scans. With that information, the FDA began requiring the makers of gadolinium drugs to include a boxed warning about the risk of NSF.
Over the years, the FDA has continued highlighting the dangers of contrasting agents in patients with renal insufficiency by updating and adding warnings to the labels.
In December 2017, the FDA started requiring a new class warning for all gadolinium-based contrast agents over concerns that the chemical agent stays in patients’ bodies years after receiving the drugs.
The latest requirements feature actions to alert health care professionals and patients about gadolinium retention. Those who may be pregnant, have had repeated scans with the agent, or have kidney problems may also be at greater risk.
Gadolinium Lawsuit Settlement: $5 Million
Since the news about the connection between NSF and gadolinium has become public, patients have started to file lawsuits against the makers of the agents for a failure to warn of complications.
In one case, plaintiff Paul Decker claimed he contracted the NSF after being injected with one of the gadolinium dyes in 2005 and sued GE Healthcare. During his trial in 2013, damaging information about GE came out suggesting that the company may have been trying to hide problems with the drug.
Decker and his family were awarded $5 million by a jury.
Companies like GE Healthcare have settled hundreds of cases out of court over the last several years from people claiming they were negligent in selling the drugs to the public. However, more lawsuits continue to be filed every month.
In November 2017, actor Chuck Norris and his wife, Gena, filed a lawsuit against three companies for $10 million over claims that their gadolinium agents nearly cost Gena her life.
“Unfortunately, litigation is the only course of action we can take to hold drug companies accountable for threatening the lives of so many innocent people who undergo MRIs,” Gena said in a statement. “These companies continue to say that there is no link between gadolinium and adverse events, even though the evidence is overwhelming that this heavy metal stays in the body for years, rather than hours.”
Advocates are hoping to get the FDA to follow the lead of the European Medicines Agency, which restricted the use of gadolinium agents and suspended the approval of others in July 2017.
Gadolinium Injury Lawsuits
With millions of people taking gadolinium-based dyes, countless people have experienced serious and unexpected side effects. As a result, thousands have filed lawsuits against the makers of GBCAs. For years, the makers of gadolinium-based contrast agents may have been aware of the risks associated with the MRI drug but failed to warn the public. As a result, people have been diagnosed with a rare disease that could lead to unexpected complications and even death.
Drug manufacturers need to be held accountable for their actions and take steps toward paying back those they harmed with their negligence.
What Claims Are We Reviewing Gadolinium Lawsuit Leads For?
Manufacturers of gadolinium-based contrast agents such as GE Healthcare have caused innocent people physical harm, emotional stress, and financial loss. Victims of this gadolinium lawsuit want to hold the manufacturers of these harmful agents responsible for their pain and suffering. Thousands of patients could be entitled to compensation for damages and Broughton Partners wants to help these victims find your law firm.
Gadolinium lawsuits are now being filed against negligent manufacturers. Our in-take process will be reviewing gadolinium lawsuit leads for the following claims:
- They failed to warn patients and doctors of gadolinium risks
- They withheld safety information from patients and doctors
- They failed to conduct proper research on the potential side effects
- They failed to look into reports of patients with normal renal function suffering severe side effects
- They designed and manufactured an MRI contrast agent that is dangerous
- They falsely marketed their product as safe to promote sales
Broughton Partners will search for gadolinium lawsuit leads via our network of websites and targeted online advertising. Patients who have suffered from gadolinium toxicity after having an MRI or MRA will be entitled to compensation for damages. Our team will review gadolinium claims for the following damages:
- Medical bills, both past and future
- Pain and suffering experienced as a result of any injuries
- Lost wages
- Loss of earning capacity
- Loss of enjoyment of life
- Punitive damages
Does Your Law Firm Need to Represent More Gadolinium Lawsuit Cases?
The ability to bring in new Gadolinium cases in a cost-effective way without sacrificing the needs of your current clients and the daily demands of your practice is a challenge at best. Broughton Partners is here to give you a competitive advantage by connecting you with more qualified Gadolinium lawsuit cases. These cases are ready, signed, and need your representation today.
Your law firm can reach new heights with Broughton Partners’ case generation services for Gadolinium lawsuit cases. Contact us today for a free consultation and learn how we can ensure there is No Claimant without a Claim.
- Dr. Nick Ferris, Professor Stacy Goergen. “Gadolinium Contrast Medium (MRI Contrast agents)”, Inside Radiology, https://www.insideradiology.com.au/gadolinium-contrast-medium/. Accessed March 20, 2019.
- MedShadow. “Is Common MRI Contrast Dye Safe? What You Need to Know”, MedShadow Foundation, https://medshadow.org/mri-gadolinium-contrast-agent/. Accessed March 20, 2019.
- RadiologyInfo.org. “Magnetic Resonance Imaging (MRI) – Body”, RadiologyInfo.org, https://www.radiologyinfo.org/en/info.cfm?pg=bodymr. Accessed March 20, 2019.
- Hubbs Grimm. “Symptoms associated with Gadolinium Toxicity”, Gadolinium Toxicity, https://gadoliniumtoxicity.com/help/symptoms/. Accessed March 20, 2019.
- MMWR Weekly. “Nephrogenic Fibrosing Dermopathy Associated with Exposure to Gadolinium-Containing Contrast Agents — St. Louis, Missouri, 2002–2006”, CDC, https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5607a1.htm. Accessed March 20, 2019.
- FDA. “FDA in Brief: FDA requires new class warning and additional research on retention in the body of gadolinium from gadolinium-based contrast agents used in magnetic resonance imaging”, U.S. Food and Drug Administration, https://www.fda.gov/newsevents/newsroom/fdainbrief/ucm589604.htm. Accessed April 14, 2019.